Véronique Marchand

638 citations
12 papers · 535 indexed · h-index 8

Véronique Marchand

12 papers receiving 526 citations

Peers

Véronique Marchand
Comparison fields: 5 of 77
  • Cancer Research 189
  • Immunology and Allergy 56
  • Hematology 73
  • Oncology 178
  • Immunology 88
Replace Thomas Brühl with:
Thomas Brühl Germany
E. A. Harding United Kingdom
Hisako Muramatsu Japan
Jun‐ichi Suehiro Japan
Simone Dario Scilabra Italy
Zhen Geng China
Mario Vallon Germany
Andrew S. Gilder United States
Annalisa Adamo Italy
Michele Pelosi Italy
Véronique Marchand relative to Thomas Brühl Germany Thomas Brühl's profile →
Citations per field
00.5×1.5×
Thomas Brühl · 1×
Citations per year

Countries citing papers authored by Véronique Marchand

Since Specialization
Citations

This map shows the geographic impact of Véronique Marchand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Véronique Marchand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Véronique Marchand more than expected).

Fields of papers citing papers by Véronique Marchand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Véronique Marchand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Véronique Marchand. The network helps show where Véronique Marchand may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Véronique Marchand, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Véronique Marchand Line = papers co-authored together Véronique Marchand links everyone, so they are left out of the graph.

All Works

12 of 12 papers shown
#Work
1 20044
2 20046
3 20044
4 200386
5 200135
6 1997116
7 199731
8 19978
9 1997121
10 199663
11 19955
12
Decreased expression of the CFTR protein in remodeled human nasal epithelium from non-cystic fibrosis patients.
199556

About Véronique Marchand

Véronique Marchand is a scholar working on Hematology, Cancer Research and Physiology, having authored 12 papers that have together received 535 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (4 papers), Protease and Inhibitor Mechanisms (4 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Glycosylation and Glycoproteins Research (1 paper), Neonatal Respiratory Health Research (1 paper), Selenium in Biological Systems (1 paper), Immunotoxicology and immune responses (1 paper) and Insect and Pesticide Research (1 paper). The work is most often cited by research in Cancer Research (189 citations), Immunology and Allergy (56 citations) and Hematology (73 citations). Véronique Marchand has collaborated with scholars based in France, United States and Japan. Frequent co-authors include Myriam Polette, Philippe Birembaut, Jean‐Marie Tournier, Étienne C. Hirsch, Karine Parain, Christine Gilles, Béatrice Nawrocki‐Raby, Michel Monteau, Philippe Gillery and Stanley Zucker. Their work appears in journals such as Biomedicine & Pharmacotherapy, Brain Research, Placenta, Journal of Histochemistry & Cytochemistry and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026